{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:04:10Z","timestamp":1777539850226,"version":"3.51.4"},"reference-count":210,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T00:00:00Z","timestamp":1102550400000},"content-version":"vor","delay-in-days":38,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The significance of CRP and inflammation has increased over time, especially in the end\u2010stage renal disease (ESRD) population. From a simple marker it now appears that CRP is an active participant in pro\u2010atherosclerotic phenomenon including local pro\u2010inflammatory and thrombotic events. Studies in the general population indicate the usefulness of CRP in prognostication and in monitoring response to therapy. The clinical usefulness of CRP monitoring in chronic kidney disease (CKD) and especially in ESRD deserves closer study. In the meantime, the utility of CRP measurements for monitoring and treatment is on a case\u2010by\u2010case basis. Management of traditional cardiovascular risk factors should be considered. In the interest of optimizing therapy it is prudent to use biocompatible membranes and ultrapure water. A careful search for infectious processes in dialysis patients is recommended, with special attention to vascular access sites, periodontitis, gastritis, and other potentially chronic or covert infections. ACE\u2010inhibitor use should be maximized in all eligible CKD patients. The data on the use of statins in ESRD have been generally positive but await further validation. Individualized use for selected patients is probably beneficial.<\/jats:p>","DOI":"10.1111\/j.0894-0959.2004.17604.x","type":"journal-article","created":{"date-parts":[[2004,12,9]],"date-time":"2004-12-09T20:51:00Z","timestamp":1102625460000},"page":"438-448","source":"Crossref","is-referenced-by-count":49,"title":["POOR NUTRITIONAL STATUS AND INFLAMMATION: C\u2010Reactive Protein and End\u2010Stage Renal Disease"],"prefix":"10.1111","volume":"17","author":[{"suffix":"Jr.","given":"Eduardo","family":"Lacson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan W.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,9]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00032.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00172.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00653-X"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.7.1277"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-1-200401060-00006"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70172-6"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00422.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00564-3"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018090-00006"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.451"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.3.353"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00273.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00410.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.8.1956"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(00)70200-9"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V13suppl_1s28"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.106"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.52.4.561"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(95)80029-8"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0496-346"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.1999.046"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-136-35323"},{"key":"e_1_2_8_24_2","first-page":"831","article-title":"Isolation of a peptido\u2010polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C\u2010reactive protein and a mouse anti\u2010phosphorylcholine myeloma serum","volume":"32","author":"Baldo BA","year":"1977","journal-title":"Immunology"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1980.tb00056.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/281155a0"},{"key":"e_1_2_8_27_2","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1016\/S0021-9258(17)39873-3","article-title":"Binding of C\u2010reactive protein to chromatin and nucleosome core particles. A possible physiological role of C\u2010reactive protein","volume":"259","author":"Robey FA","year":"1984","journal-title":"J Biol Chem"},{"key":"e_1_2_8_28_2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4049\/jimmunol.146.4.1220","article-title":"Analysis of the binding of C\u2010reactive protein to chromatin subunits","volume":"146","author":"Du Clos TW","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_8_29_2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0021-9258(17)43435-1","article-title":"Binding of fibronectin by the acute phase reactant C\u2010reactive protein","volume":"259","author":"Salonen EM","year":"1984","journal-title":"J Biol Chem"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(89)90059-1"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240400112"},{"key":"e_1_2_8_32_2","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.125.5.1933","article-title":"Binding reactivity of C\u2010reactive protein for polycations","volume":"125","author":"DiCamelli R","year":"1980","journal-title":"J Immunol"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.156.1.230"},{"key":"e_1_2_8_34_2","first-page":"237","article-title":"Circulating human C\u2010reactive protein binds very low density lipoproteins","volume":"58","author":"Rowe IF","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_35_2","first-page":"2135","article-title":"Interaction of C\u2010reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C\u2010reactive protein with pneumococcal C\u2010polysaccharide and with the choline phosphatides, lecithin and sphingomyelin","volume":"112","author":"Kaplan MH","year":"1974","journal-title":"J Immunol"},{"key":"e_1_2_8_36_2","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.4049\/jimmunol.146.7.2324","article-title":"Binding and complement activation by C\u2010reactive protein via the collagen\u2010like region of C1q and inhibition of these reactions by monoclonal antibodies to C\u2010reactive protein and C1q","volume":"146","author":"Jiang HX","year":"1991","journal-title":"J Immunol"},{"key":"e_1_2_8_37_2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4049\/jimmunol.136.4.1354","article-title":"Binding of C\u2010reactive protein to nucleated cells leads to complement activation without cytolysis","volume":"136","author":"Berman S","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_8_38_2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4049\/jimmunol.145.2.650","article-title":"Complement activation induced by human C\u2010reactive protein in mildly acidic conditions","volume":"145","author":"Miyazawa K","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_8_39_2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.119.5.1611","article-title":"Mediation of CRP\u2010dependent phagocytosis through mouse macrophage Fc\u2010receptors","volume":"119","author":"Mortensen RF","year":"1977","journal-title":"J Immunol"},{"key":"e_1_2_8_40_2","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.4049\/jimmunol.155.4.2185","article-title":"C\u2010reactive protein binds to Fc gamma RI in transfected COS cells","volume":"155","author":"Marnell LL","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.4.585"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.1.179"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.3.1514"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7817"},{"key":"e_1_2_8_45_2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.4049\/jimmunol.155.5.2557","article-title":"Human C\u2010reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice","volume":"155","author":"Szalai AJ","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.4.631"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.12.7019"},{"key":"e_1_2_8_48_2","first-page":"5084","article-title":"Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C\u2010reactive protein","volume":"42","author":"Deodhar SD","year":"1982","journal-title":"Cancer Res"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00205420"},{"key":"e_1_2_8_50_2","first-page":"5077","article-title":"Macrophage tumoricidal activity induced by human C\u2010reactive protein","volume":"46","author":"Zahedi K","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_8_51_2","first-page":"3959","article-title":"Activation of human monocyte tumoricidal activity by C\u2010reactive protein","volume":"47","author":"Barna BP","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_8_52_2","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4049\/jimmunol.137.7.2173","article-title":"Detection of C\u2010reactive protein, streptolysin O, and anti\u2010streptolysin O antibodies in immune complexes isolated from the sera of patients with acute rheumatic fever","volume":"137","author":"Gupta RC","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_8_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518709168951"},{"key":"e_1_2_8_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.6.468"},{"key":"e_1_2_8_55_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.6.1344"},{"key":"e_1_2_8_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(92)90079-7"},{"key":"e_1_2_8_57_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.2.513.513"},{"key":"e_1_2_8_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.53.4.439"},{"key":"e_1_2_8_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.18.2165"},{"key":"e_1_2_8_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.21.2531"},{"key":"e_1_2_8_61_2","first-page":"339","article-title":"Human C\u2010reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome","volume":"115","author":"Kew RR","year":"1990","journal-title":"J Lab Clin Med"},{"key":"e_1_2_8_62_2","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.161.5.2533","article-title":"Effect of human C\u2010reactive protein on chemokine and chemotactic factor\u2010induced neutrophil chemotaxis and signaling","volume":"161","author":"Zhong W","year":"1998","journal-title":"J Immunol"},{"key":"e_1_2_8_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(88)80195-9"},{"key":"e_1_2_8_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340813"},{"issue":"6","key":"e_1_2_8_65_2","first-page":"L649","article-title":"Inhibition of C5a des Arg\u2010induced neutrophil alveolitis in transgenic mice expressing C\u2010reactive protein","volume":"266","author":"Heuertz RM","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_8_66_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.3.8630558"},{"key":"e_1_2_8_67_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.6.2575"},{"key":"e_1_2_8_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02918367"},{"key":"e_1_2_8_69_2","first-page":"15","article-title":"Platelet inhibitory effects of CRP preparations are due to a co\u2010isolating low molecular weight factor","volume":"45","author":"Fiedel BA","year":"1982","journal-title":"Immunology"},{"key":"e_1_2_8_70_2","first-page":"439","article-title":"Activation of platelets by modified C\u2010reactive protein","volume":"45","author":"Fiedel BA","year":"1982","journal-title":"Immunology"},{"key":"e_1_2_8_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(83)90140-2"},{"key":"e_1_2_8_72_2","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1016\/S0021-9258(18)48201-4","article-title":"Proteolysis of human C\u2010reactive protein produces peptides with potent immunomodulating activity","volume":"262","author":"Robey FA","year":"1987","journal-title":"J Biol Chem"},{"key":"e_1_2_8_73_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.143.1.221"},{"key":"e_1_2_8_74_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902113400607"},{"key":"e_1_2_8_75_2","first-page":"120","article-title":"Radioimmunoassay of human C\u2010reactive protein and levels in normal sera","volume":"87","author":"Claus DR","year":"1976","journal-title":"J Lab Clin Med"},{"key":"e_1_2_8_76_2","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/S0021-9258(18)89246-8","article-title":"Secretion of C\u2010reactive protein becomes more efficient during the course of the acute phase response","volume":"260","author":"Macintyre SS","year":"1985","journal-title":"J Biol Chem"},{"key":"e_1_2_8_77_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.118.2.253"},{"key":"e_1_2_8_78_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.36.22245"},{"key":"e_1_2_8_79_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116336"},{"key":"e_1_2_8_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120517"},{"key":"e_1_2_8_81_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1243"},{"key":"e_1_2_8_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.3.444"},{"key":"e_1_2_8_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02786357"},{"key":"e_1_2_8_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2143(97)90060-3"},{"key":"e_1_2_8_85_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.713"},{"key":"e_1_2_8_86_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.1.65"},{"key":"e_1_2_8_87_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1309"},{"key":"e_1_2_8_88_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1999.70.11.1355"},{"key":"e_1_2_8_89_2","doi-asserted-by":"publisher","DOI":"10.1159\/000065018"},{"key":"e_1_2_8_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.3.590"},{"key":"e_1_2_8_91_2","first-page":"977","article-title":"Biodistribution and clearance of 125I\u2010labeled C\u2010reactive protein and 125I\u2010labeled modified C\u2010reactive protein in CD\u20101 mice","volume":"26","author":"Motie M","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_8_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2006.01750.x"},{"key":"e_1_2_8_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00353-6"},{"key":"e_1_2_8_94_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188638"},{"key":"e_1_2_8_95_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186176"},{"key":"e_1_2_8_96_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.30545"},{"key":"e_1_2_8_97_2","first-page":"452","article-title":"Effect of the hemodialysis membrane on the inflammatory reaction in vivo","volume":"53","author":"Schindler R","year":"2000","journal-title":"Clin Nephrol"},{"key":"e_1_2_8_98_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.3.379"},{"key":"e_1_2_8_99_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-199809000-00018"},{"key":"e_1_2_8_100_2","first-page":"288","article-title":"Factors affecting low values of serum albumin in CAPD patients","volume":"12","author":"Han DS","year":"1996","journal-title":"Adv Perit Dial"},{"key":"e_1_2_8_101_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.72"},{"key":"e_1_2_8_102_2","first-page":"153","article-title":"Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients","volume":"17","author":"Pilkey RM","year":"2001","journal-title":"Adv Perit Dial"},{"key":"e_1_2_8_103_2","first-page":"371","article-title":"Serum C\u2010reactive protein as a marker for infection and inflammation in regular dialysis patients","volume":"48","author":"McIntyre C","year":"1997","journal-title":"Clin Nephrol"},{"key":"e_1_2_8_104_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/089686089601600213","article-title":"Chronic induction of C\u2010reactive protein by hemodialysis, but not by peritoneal dialysis therapy","volume":"16","author":"Haubitz M","year":"1996","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_105_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186276"},{"key":"e_1_2_8_106_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00470.x"},{"key":"e_1_2_8_107_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.36330"},{"key":"e_1_2_8_108_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.4.809"},{"key":"e_1_2_8_109_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.30546"},{"issue":"3","key":"e_1_2_8_110_2","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1177\/089686080102103S26","article-title":"Helicobacter pylori infection: a new cause of anorexia in peritoneal dialysis patients","volume":"21","author":"Aguilera A","year":"2001","journal-title":"Perit Dial Int"},{"key":"e_1_2_8_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2003.11.023"},{"key":"e_1_2_8_112_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.61.s80.10.x"},{"key":"e_1_2_8_113_2","first-page":"353","article-title":"Vascular access, an underestimated source of inflammation in dialysis patients","volume":"24","author":"Canaud B","year":"2003","journal-title":"Nephrologie"},{"key":"e_1_2_8_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90339-5"},{"key":"e_1_2_8_115_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1998.00323.x"},{"key":"e_1_2_8_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70259-3"},{"key":"e_1_2_8_117_2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood.V91.4.1235","article-title":"Fas ligand is present in human erythroid colony\u2010forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis","volume":"91","author":"Dai CH","year":"1998","journal-title":"Blood"},{"key":"e_1_2_8_118_2","first-page":"204","article-title":"Inhibition of CFU\u2010E colony formation in uremic patients with inflammatory disease: role of IFN\u2010gamma and TNF\u2010alpha","volume":"47","author":"Allen DA","year":"1999","journal-title":"J Invest Med"},{"key":"e_1_2_8_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.suppl_1.48"},{"key":"e_1_2_8_120_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.8.1207"},{"key":"e_1_2_8_121_2","doi-asserted-by":"publisher","DOI":"10.1159\/000064087"},{"key":"e_1_2_8_122_2","first-page":"422","article-title":"Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy","volume":"49","author":"Sirken G","year":"2003","journal-title":"ASAIO J"},{"key":"e_1_2_8_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/217578a0"},{"key":"e_1_2_8_124_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02020747"},{"key":"e_1_2_8_125_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057469"},{"key":"e_1_2_8_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80134-X"},{"key":"e_1_2_8_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)81060-2"},{"key":"e_1_2_8_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70281-7"},{"key":"e_1_2_8_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70282-9"},{"key":"e_1_2_8_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70174-X"},{"key":"e_1_2_8_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2003.11.022"},{"key":"e_1_2_8_132_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113000"},{"key":"e_1_2_8_133_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00804.x"},{"key":"e_1_2_8_134_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.021"},{"key":"e_1_2_8_135_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.9.1863"},{"key":"e_1_2_8_136_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33393"},{"key":"e_1_2_8_137_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.11.008"},{"key":"e_1_2_8_138_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000053730.47739.3C"},{"key":"e_1_2_8_139_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"e_1_2_8_140_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000125690.80303.A8"},{"key":"e_1_2_8_141_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032804"},{"key":"e_1_2_8_142_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.7.932"},{"key":"e_1_2_8_143_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.37389"},{"key":"e_1_2_8_144_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.s84.25.x"},{"key":"e_1_2_8_145_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50005"},{"key":"e_1_2_8_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00655-3"},{"key":"e_1_2_8_147_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901143400207"},{"key":"e_1_2_8_148_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1995.tb03515.x"},{"key":"e_1_2_8_149_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.9.1386"},{"key":"e_1_2_8_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00105-7"},{"key":"e_1_2_8_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64051-5"},{"key":"e_1_2_8_152_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000096055.62724.C5"},{"key":"e_1_2_8_153_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.11.030"},{"key":"e_1_2_8_154_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00170.2003"},{"key":"e_1_2_8_155_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000015126.83143.B4"},{"key":"e_1_2_8_156_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029802.88087.5E"},{"key":"e_1_2_8_157_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200311000-00005"},{"key":"e_1_2_8_158_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.9.1194"},{"key":"e_1_2_8_159_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000061916.95736.E5"},{"key":"e_1_2_8_160_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000125526.91945.AE"},{"key":"e_1_2_8_161_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052617.91920.FD"},{"key":"e_1_2_8_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2003.07.026"},{"key":"e_1_2_8_163_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000117087.27524.0E"},{"key":"e_1_2_8_164_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205378200"},{"key":"e_1_2_8_165_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000125527.41598.68"},{"key":"e_1_2_8_166_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000085568.13915.1E"},{"key":"e_1_2_8_167_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000114526.50618.24"},{"key":"e_1_2_8_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.11.017"},{"key":"e_1_2_8_169_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127419.45975.26"},{"key":"e_1_2_8_170_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.12.1183"},{"key":"e_1_2_8_171_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363820"},{"key":"e_1_2_8_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(01)00703-1"},{"key":"e_1_2_8_173_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000084640.21712.9C"},{"key":"e_1_2_8_174_2","first-page":"174","article-title":"CD14 (C\u2010159\u2192T) polymorphism and levels of C\u2010reactive protein","volume":"142","author":"Hubacek JA","year":"2003","journal-title":"Cas Lek Cesk"},{"key":"e_1_2_8_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.05.001"},{"key":"e_1_2_8_176_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.2001.0974"},{"key":"e_1_2_8_177_2","first-page":"168","article-title":"Interleukin 1B gene polymorphism is associated with baseline C\u2010reactive protein levels in healthy individuals","volume":"14","author":"Eklund C","year":"2003","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_8_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00534-X"},{"key":"e_1_2_8_179_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020092"},{"key":"e_1_2_8_180_2","doi-asserted-by":"publisher","DOI":"10.1159\/000046994"},{"key":"e_1_2_8_181_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.10.1814"},{"key":"e_1_2_8_182_2","doi-asserted-by":"publisher","DOI":"10.1177\/039139880302600105"},{"key":"e_1_2_8_183_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.16106.x"},{"key":"e_1_2_8_184_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5864"},{"key":"e_1_2_8_185_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802609"},{"key":"e_1_2_8_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2003.11.022"},{"key":"e_1_2_8_187_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802617"},{"key":"e_1_2_8_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.09.046"},{"key":"e_1_2_8_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.10.041"},{"key":"e_1_2_8_190_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.3.242"},{"key":"e_1_2_8_191_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04170-2"},{"key":"e_1_2_8_192_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.2000.00738.x"},{"key":"e_1_2_8_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.07.050"},{"key":"e_1_2_8_194_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t\u2010PA, PAI and C\u2010reactive protein\u2014a cross\u2010sectional population survey","volume":"86","author":"Lowe GD","year":"2001","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_195_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401"},{"key":"e_1_2_8_196_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.8.793"},{"key":"e_1_2_8_197_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1797.8.s.8.x"},{"key":"e_1_2_8_198_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000099124.84425.BB"},{"key":"e_1_2_8_199_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(03)00158-8"},{"key":"e_1_2_8_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.12.010"},{"key":"e_1_2_8_201_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00560.x"},{"key":"e_1_2_8_202_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000051361.69808.3A"},{"key":"e_1_2_8_203_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.05.006"},{"key":"e_1_2_8_204_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000097301.50041.6E"},{"key":"e_1_2_8_205_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106283442601"},{"key":"e_1_2_8_206_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.1.64"},{"key":"e_1_2_8_207_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.9.1071"},{"key":"e_1_2_8_208_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103624.14436.4B"},{"key":"e_1_2_8_209_2","first-page":"238","article-title":"Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C\u2010reactive protein and in vivo oxidized LDL","volume":"16","author":"Van Den Akker JM","year":"2003","journal-title":"J Nephrol"},{"key":"e_1_2_8_210_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.20739"},{"key":"e_1_2_8_211_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2003.16036.x"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0894-0959.2004.17604.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0894-0959.2004.17604.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T19:40:51Z","timestamp":1697139651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0894-0959.2004.17604.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":210,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.0894-0959.2004.17604.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0894-0959.2004.17604.x","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}